A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome

NCT03703908 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped Program not advancing

Conditions

Interventions

Sponsor

Amgen